
Discussions about whether a research peptide is "legal" usually collapse three separate categories into one. It's worth keeping them distinct: licensed prescription medicines that have completed formal drug registration and are marketed under an approved brand for human therapeutic use; controlled or scheduled substances covered by narcotics and psychotropic legislation; and unscheduled research chemicals — laboratory-grade materials supplied for research purposes, explicitly labelled not for human consumption.
BPC-157, as supplied by REVIVE LAB UAE, sits in the third category. It is not a narcotic, it is not scheduled as a controlled substance, and it is not marketed anywhere as an approved prescription drug under a specific brand name. That places it in a different regulatory position than a registered pharmaceutical product, even though the underlying gastrointestinal and soft-tissue research literature is extensive.
BPC-157 is a synthetic pentadecapeptide derived from a partial sequence found in gastric juice, and it has been the subject of a large body of preclinical research into tissue-repair pathways. Despite that research volume, BPC-157 has not, to REVIVE's knowledge, completed the formal registration and approval process required to be marketed as a licensed prescription medicine under any brand name in the UAE or elsewhere. Because it is neither an approved pharmaceutical product nor a scheduled substance, research-grade BPC-157 supplied with clear non-human-consumption labelling generally falls into the unscheduled research-chemical category.
This is a general, high-level description of how the category works, not a specific legal determination for any individual shipment, institution, or use case. Regulatory interpretation can vary by circumstance, and REVIVE LAB UAE is not a law firm — for certainty on your own situation, consult UAE customs, MOHAP, or a qualified lawyer.
Separately from classification, anyone personally importing any product into the UAE — pharmaceutical, supplement, or research chemical — is generally responsible for understanding what documentation, declarations, and permits their specific shipment may require, and for how customs treats that parcel on arrival. Personal international shipments can be delayed or held while contents, origin, and labelling are verified, with the buyer typically carrying that administrative burden directly. This is a practical reality of cross-border parcel logistics, independent of the underlying compound's classification.
REVIVE LAB UAE holds BPC-157 in stock domestically and dispatches from inside the UAE, so a purchase is a domestic transaction rather than a personal international import. The buyer isn't the one filing customs declarations, dealing with international carriers, or absorbing the risk of a parcel being queried at the border — one of the main reasons UAE-based research groups increasingly prefer sourcing locally over ordering directly from overseas vendors.
REVIVE's BPC-157 listings are deliberately narrow in scope: research-use-only labelling on every vial, no human dosing or therapeutic claims on our product pages, and nothing on this site should be read as medical or clinical guidance. REVIVE does not claim MOHAP drug registration or any pharmaceutical marketing authorisation — it operates as a supplier of laboratory-grade research material, and it is the buyer's responsibility to use that material appropriately and in line with the rules that apply to their own research context.
| Spec | Detail |
|---|---|
| Form | Lyophilised powder, 5 mg vial |
| Molecular weight | ≈1419 Da |
| Purity (HPLC) | ≥99.2% |
| Class | Pentadecapeptide, 15 amino acids |
| Labelling | Research use only — not for human or veterinary use |
| Price | AED 249 per 5 mg vial |
Research-grade BPC-157 supplied for laboratory and research purposes is generally classified as an unscheduled research chemical rather than a controlled substance or licensed prescription pharmaceutical in the UAE. This is general information, not legal advice — confirm specifics with UAE customs, MOHAP, or a qualified lawyer for your situation.
BPC-157 is not currently marketed as a licensed prescription pharmaceutical under any brand name in any major market, and research-grade material is not treated as a narcotic or scheduled drug when correctly labelled for laboratory use.
Buying from a UAE-based supplier already holding domestic stock avoids the customs paperwork, delays, and interception risk of personal international shipments.
No. REVIVE does not claim MOHAP registration or any specific regulatory approval — it supplies HPLC-verified research material with clear non-human-consumption labelling.